270 articles
Thomas Carpenter, M.D., talks about the recent FDA approval (April 2018) of Crysvita® (burosumab-twza) for the treatment of X-Linked Hypophosphatemia (...
Kakkis, M.D., Ph.D., CEO and President of Ultragenyx discusses the recently FDA approved (April 2018) Crysvita® (burosumab-twza) for the treatment of X...
Guest: Andrew Ritter Presenter: Neal Howard Guest Bio: Mr. Learn more on Health Professional Radio.
serves as AMAG’s chief medical officer and senior vice president of clinical development and regulatory affairs. Learn more on Health Professional Radio.
Faith, is an award-winning Oral Surgeon in private practice in the Dallas, Texas-area. Learn more on Health Professional Radio.
Segment Overview: Bob Miglani, Chief of Business Development at Applied DNA Sciences discusses securing the pharmaceutical supply chain which is a lar...
Cris Beer is an integrative/holistic medical doctor, author, corporate speaker, and media doctor. Learn more on Health Professional Radio.
Segment Overview: Jeff Miller, General Manager of the Givosiran program at Alnylam discusses the ENVISION Alnylam Phase 3 trial of its investigational R...
Jason Stein, MD Presenter: Neal Howard Guest Bio: Jason Stein, MD, is an attending orthopaedic surgeon at the MedStar Union Memorial Hospital.
Arthur Kavanaugh discusses the recent (Oct 2017) FDA approval of SIMPONI ARIA ® (golimumab) as the first and only fully-human anti-tumor necrosis facto...